Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
about
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewCirculating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed CandidatesA circulating permeability factor in focal segmental glomerulosclerosis: the hunt continuessuPAR as a prognostic biomarker in sepsisSLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activatorPlasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.Effects of Acute Exercise on Circulating Soluble Form of the Urokinase Receptor in Patients With Major Depressive Disorder.Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infectionSoluble urokinase plasminogen activator receptor as a marker for use of antidepressants.Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatmentUrokinase and its receptors in chronic kidney disease.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptorRecent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly PatientsPlasma Levels of Intact and Cleaved Urokinase Receptor Decrease in HIV-1-Infected Patients Initiating Highly Active Antiretroviral TherapysuPAR as a marker of infection in acute kidney injury - a prospective observational study
P2860
Q24614787-3997AE60-AE53-4BF2-8CBE-48F3D63ECCC0Q26747221-5A90B77C-29D8-4A97-925F-779A190AEF42Q26776389-F9DA62AB-B9E1-454D-80CE-77039F0D7ECDQ26858996-D955FE9F-6DED-4134-AAB6-F0E07A61ED6EQ28115141-A5CF20B0-7883-4286-A151-36EBFDAAEC2DQ33284948-8728AF8B-1CE0-4F15-8B9E-4FB0ACD5D43EQ33580655-B9C2A064-5089-42B7-A21A-F9CF98777D9CQ34231973-56C01013-0499-44E7-AAC8-D52DAE70004DQ34374238-AD245760-229F-4D3E-8F28-76F23AC7AD57Q34399577-8F5ED160-1A00-4485-BF0D-A247D924CB6AQ35124141-87BC44AF-B531-40DE-A355-ADBB290EFC82Q38164339-05A4DBA7-4753-4391-B6B3-196C62C1EB06Q39335899-0B6A8AD3-AAA3-42BD-A56D-6001AB61196DQ40257524-65B2925D-B5C7-442B-B5DF-A2C1E500EBD2Q41453402-E00DEE57-127A-4302-8408-0A6F6C391B7CQ57609583-A67BA52A-195F-4229-9FBC-16DB5DCD24E1Q58803154-4BF00322-6531-4FA6-9823-08E9ED1F9876
P2860
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
@en
type
label
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
@en
prefLabel
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
@en
P2093
P1433
P1476
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia.
@en
P2093
Claessen N
Florquin S
Olszyna DP
Weening JJ
van den Berg JG
van der Poll T
P304
P356
10.1046/J.1523-1755.2001.0590062054.X
P407
P577
2001-06-01T00:00:00Z